15Dec
Life Sciences Dealmaking Symposium: Powering through the Pandemic: Trends in Early-Stage Investment
The pursuit of progress during these unprecedented times has led to a surge in life sciences investment and funding for early stage companies. Investors are on the lookout for the next big innovation while also navigating new ways of sourcing and managing portfolio companies. Our panel of experienced early-stage investors discussed the top trends in this push for advancement, including sectors attracting the most dollars in today’s challenging business landscape, key issues that early stage...
By:
McDermott Will & Emery
Related
On Friday afternoon, the Supreme Court of the United States granted certiorari in three cases: Barr...
Read More >
Buyout firms must beware the unique legal, regulatory, and commercial issues that can complicate spo...
Read More >
On July 17, 2019, the Supreme Court of Ohio announced a major victory for the Ohio construction indu...
Read More >
Employers in New Jersey and New York City need to review their drug testing policies and employment ...
Read More >
The Federal Trade Commission (“FTC”) has announced the annual revisions to the Hart-Scott-Rodino A...
Read More >
On August 12, 2019, the National Labor Relations Board (NLRB) issued three proposed amendments to th...
Read More >